Compliance with
European regulations

VedaLab

Distribution in
170 + countries

VedaLab

ISO 13485
certified company

VedaLab

POC European
leader

VedaLab

New products

DRUGS OF ABUSE FOR HOME USE

DRUGS OF ABUSE FOR HOME USE

Several rapid tests for drugs of Abuse detection (one drug/test) are now available for home use: Cannabinoid, cocaine, opiates, amphetamines, […]

Read more
CALPROTECTIN’ALERT

CALPROTECTIN’ALERT

Home use rapid test for the detection of faecal calprotectin associated to intestinal inflammation. This test is now CE marked. […]

Read more
COVID-19-CHECK-1 ANTIGEN

COVID-19-CHECK-1 ANTIGEN

Immunochromatographic rapid test for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal swab samples. The COVID-19-CHECK-1 Antigen test is a […]

Read more

Exhibition

MEDLAB EXHIBITION

MEDLAB EXHIBITION

We will exhibit at MEDLAB exhibition from February 5th to 8th, 2024 in DUBAI, United Arab Emirates. We will be […]

Read more

Information

Syphilis Health Check

The Syphilis Health Check test manufactured by VEDALAB has been granted by FDA on December 15th, 2014 the first-ever CLIA […]

Read more

Ebola Rapid Test

VedaLab is very proud to announce that, in collaboration with the CEA (Commissariat à l’Energie Atomique), its very reputable R&D […]

Read more
VedaLab

VEDALAB is a privately owned French company, founded in 1991.

VEDALAB is devoted to the development, production and marketing of in vitro immunodiagnostic rapid tests. As a  market leader, VEDALAB focuses on international expansion by forming long-term partnerships with reliable and trustworthy distributors worldwide.  Continually expanding its already broad range of products, VEDALAB is as of today the biggest real manufacturer of rapid tests in Europe.

Learn more